| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |